Full-Dose Blood Thinners – COVID-19 Treatment

Angie SzumlinskiHealth, Studies

In large clinical trials conducted worldwide, full-dose anticoagulation (blood thinner) treatments given to moderately ill patients hospitalized for COVID-19 reduced the requirement of vital organ support, such as the need for mechanical ventilation. A trend in possible reduction of mortality was also observed and is being further studied. With large numbers of COVID-19 patients requiring hospitalization, these outcomes could also …

Anticoagulation Therapy – COVID-19

Angie SzumlinskiHealth, Studies

Since the first cases of COVID-19 were identified in the United States, we have learned a lot however as with anything else in life, we never stop learning! Many residents in our care contracted the COVID-19 virus and required hospitalization. Some of these residents developed blood clots in the lungs, negatively impacting their recovery. Anticoagulation therapy has become common practice …